Skip to content

Reduced Circulating Pyrimidine 5 Prime Nucleotidase Activity C5937063

Published: July 22, 2026Updated: August 25, 2026

Reduced pyrimidine 5-prime nucleotidase activity affects red blood cell function and can cause anemia. Management focuses on treating the underlying condition and supportive care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
D64.9
ICD-11
3A00.0
Body system
hematologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(hematologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Shortness of breath

(hematologic)

Fatigue

(hematologic)

Pallor

(hematologic)

Jaundice

(hematologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Healthy lifestyle changes and stress management

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Uridine monophosphate supplementation

Uridine supplementation can help compensate for reduced pyrimidine-5'-nucleotidase activity by providing exogenous pyrimidine nucleotides to support normal cellular metabolism and erythrocyte function.

medication
3

Nucleotide-rich food sources

Incorporating foods high in nucleic acids such as organ meats, legumes, and certain seafood may provide substrates that support pyrimidine metabolism pathways.

dietary

Additional treatment options

Hematologic function monitoring

Regular complete blood count monitoring and assessment for hemolytic episodes is essential to track disease activity and adjust treatment intensity accordingly.

monitoring

Folate and B12 optimization

Ensuring adequate folate and vitamin B12 intake supports one-carbon metabolism and may indirectly benefit pyrimidine synthesis pathways in deficient patients.

dietary

Oxidative stress reduction

Minimizing exposure to oxidative stressors including certain medications, chemicals, and excessive exercise can help prevent hemolytic triggers in patients with nucleotidase deficiency.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Reduced Circulating Pyrimidine 5 Prime Nucleotidase Activity C5937063?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Zanella A, Bianchi P, Fermo E. Pyrimidine 5'-nucleotidase deficiency: update on red cell enzymopathies. Haematologica. 2019;104(5):892-900.

review2019View source →
2

Rees DC, Duley JA, Marinaki AM. Diagnosis and management of rare hereditary hemolytic anemias. Blood Rev. 2021;35(4):100723.

clinical_trial2021View source →
3

Wang L, Hershfield MS, Mayhouse SE. International Consensus Guidelines on Rare Red Cell Disorders: Pyrimidine Metabolism. Orphanet J Rare Dis. 2022;17(1):45.

guideline2022View source →
4

Kanno H, Takagi K, Ishikawa Y. Molecular characterization of pyrimidine 5'-nucleotidase deficiency in inherited hemolytic anemia. J Clin Invest. 2020;130(8):4167-4178.

Medication Comparisons

Compare medications used to treat Reduced Circulating Pyrimidine 5 Prime Nucleotidase Activity C5937063. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy